Pharmafile Logo
Pharmafocus logo
Advanced Search

Biotec strengthens team with new appointments

May 22, 2012
Manufacturing and Production

Bridgend, Wales: Biotec Services International has announced the appointment of two senior industry professionals as the company embarks on an …

Appointment

UCB signs new epilepsy research pact with Imperial

May 21, 2012
Research and Development, Sales and Marketing R&D, Scotland, UCB, epilepsy

UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …

News

ICON makes two senior appointments

May 21, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRO, ICON, appointment

ICON has appointed Dr Susan Anton as director of epidemiology and risk management practice, and late phase and outcomes research. …

Appointment

Ovarian cancer charity wins GSK/King’s Fund award

May 21, 2012
Medical Communications, Sales and Marketing GSK, awards, charity, king's fund, ovarian cancer

A charity which aims to increase the chances of survival for patients with a poorly-treated form of cancer is to …

News

World’s first stem cell drug approved in Canada

May 21, 2012
Sales and Marketing Canada, regenerative medicine, stem cell

Canada has approved the world’s first stem cell drug, marking an historic day for the burgeoning therapy.  Osiris’ Prochymal is …

News

GSK buys more of Theravance

May 18, 2012
Research and Development, Sales and Marketing COPD, Cellzome, GSK, Relovair, Theravance

GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …

News

OPEN Health invests in Harvey Walsh

May 18, 2012
Medical Communications Harvey Walsh, Open Health

Harvey Walsh, a market access and healthcare intelligence company, is to join forces with OPEN Health, the healthcare communications group.  OPEN Health …

News
screen_shot_2012-05-18_at_09

Teva re-elects Chairman of the Board

May 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frost, Teva

Teva has announced that its Board of Directors has unanimously voted to re-elect Dr Phillip Frost as Chairman of the …

Appointment

Plavix loses US patent protection

May 18, 2012
Sales and Marketing BMS, FDA, Lipitor, Pfizer, Plavix, Sanofi

Sanofi and Bristol-Myers Squibb’s blood thinner Plavix has lost its patent protection in the US.  The drug, which made $6.6 …

News
Andrew Lansley

NICE to be sidelined on cost effectiveness – once again

May 17, 2012
Sales and Marketing NICE, VBP

Health secretary Andrew Lansley has confirmed that NICE will no longer direct the NHS on the cost effectiveness of drugs. …

News
NICE image

NICE comes out fighting against appraisal delays story

May 17, 2012
Sales and Marketing Daily Mail, Dillon, NHS, NICE, Pfizer, Victrelis

NICE has criticised a report that says the watchdog has taken up to nine years to appraise certain drugs.   The …

News

Medivir appoints commercial executive vice president

May 17, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Juserius, Medivir

Research-based speciality firm Medivir has appointed Henric Juserius to be the new head of the company’s commercial activities.  Juserius who …

Appointment
Nexavar image

Torisel fails in head-to-head study with Nexavar

May 16, 2012
Research and Development, Sales and Marketing Bayer, Nexavar, Pfizer, Torisel, inlyta, rcc

Pfizer’s kidney cancer drug Torisel has failed to best Bayer’s Nexavar in a head-to-head trial.  The Phase III study was …

News

Pharma funds drug discovery partnership

May 16, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dundee, MRC, drug discovery, funding, partnerships, pharma

Half a dozen pharma firms are contributing £14.4 million to work by Dundee University and the Medical Research Council (MRC) on …

News
Erbitux image

Merck KGaA’s colon cancer drug fails trial

May 16, 2012
Research and Development, Sales and Marketing Erbitux, Merck KGaA, Merck Serono, colon cancer

Merck KGaA has suffered a setback with key brand Erbitux as the colerectal cancer drug failed in a late-stage trial.  …

News

Capturing the Brazilian pharma opportunity

May 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brazil, McKinsey, market access, middle class, pharma

 Many multinationals are hungry to sell their goods and services to the emerging markets’ growing middle class, comprising nearly two …

Feature
Zytiga image

Price cut sways NICE on Zytiga

May 16, 2012
Sales and Marketing Jevtana, NICE, Zytiga, prostate cancer

NICE is recommending Janssen’s prostate cancer pill Zytiga, reversing its previous stance.  In its final guidance, the watchdog is recommending …

News

Open Health appoints new digital designer

May 16, 2012
Business Services, Medical Communications, Sales and Marketing Open Health

Leo Jacobs has been appointed by Open Health as a digital designer to sit within its OPEN Source team. The …

Appointment

Merck KGaA sets out savings target as staff threaten to strike

May 15, 2012
Research and Development, Sales and Marketing Merck KGaA, R&D, Serono, cuts

Merck KGaA has outlined its plan to make €300 million in savings from its Serono drugs unit, with over half …

News

CoreLab Partners collaborates at industry conferences worldwide

May 15, 2012
Research and Development

Princeton, NJ May 15, 2012 – CoreLab Partners, Inc, a leading independent core lab providing centralized cardiac safety services and …

News
Press release
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026